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Abstract
Aim: This descriptive review aimed to assess the characteristics and methodological quality of economic
evaluations of cardiac rehabilitation (CR) programs according to updated economic guidelines for healthcare
interventions. Recommendations will be made to inform future research addressing the impact of a physical
exercise component on cost-effectiveness.
Methods: Electronic databases were searched for economic evaluations of exercise-based CR programs published in
English between 2000 and 2014. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
was used to review the methodological quality of included economic evaluations.
Results: Fifteen economic evaluations met the review inclusion criteria. Assessed study characteristics exhibited wide
variability, particularly in their economic perspective, time horizon, setting, comparators and included costs, with
significant heterogeneity in exercise dose across interventions. Ten evaluations were based on randomised
controlled trials (RCTs) spanning 6–24 months but often with weak or inconclusive results; two were modelling studies;
and the final three utilised longer time horizons of 3.5–5 years from which findings suggest that long-term exercise-
based CR results in lower costs, reduced hospitalisations and a longer cumulative patient lifetime. None of the 15 articles
met all the CHEERS quality criteria, with the majority either fully or partially meeting a selection of the assessed variables.
Conclusion: Evidence exists supporting the cost-effectiveness of exercise-based CR for cardiovascular disease patients.
However, variability in CR program delivery and weak consistency between study perspective and design limits study
comparability and therefore the accumulation of evidence in support of a particular exercise regime. The generalisability
of study findings was limited due to the exclusion of patients with comorbidities as would typically be found in a real-
world setting. The use of longer time-horizons would be more comparable with a chronic condition and enable
economic assessments of the long-term effects of CR. As none of the articles met recent reporting standards for the
economic assessment of healthcare interventions, it is recommended that future studies adhere to such guidelines.
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Introduction
The global individual and economic burden of cardio-
vascular disease demands continual innovation of pre-
vention and treatment strategies for effective patient
management [1, 2]. Competition between interventions
is accentuated by increasing financial constraints on
healthcare resources [2]. Economic evaluations provide a
useful comparative approach for effective and efficient
policy and decision-making considering both costs and
consequences on patient outcomes [3, 4].
Cardiac rehabilitation (CR) programs are a standard
part of cardiac patient care [5]. Exercise is recognised as
a core component of CR and is provided alone, or within
a multidisciplinary program combining risk factor
management, behaviour modification and psychosocial
support [6, 7].
For cardiac patients, the cost-effectiveness of CR com-
pared to standard care has been estimated to cost be-
tween USD$2000–$28,000 per life-year gained or
leading to increased health-related quality of life (HRQL)
at a cost of USD$700–$16,000 per quality-adjusted life-
year (QALY) gained [3].
With new CR service-delivery models emerging and
healthcare resources becoming more limited, it is timely
to reassess the cost-effectiveness of CR-services. Also
with the recent development of updated standards for
economic evaluations of healthcare interventions, it is
necessary to bring the findings of previous reviews [3, 5]
into context with these guidelines as to provide a plat-
form for future studies looking at the cost-effectiveness
of CR services to build upon. With that in mind, this
systematic review aims to understand how economic
evaluations of exercise-based CR are conducted with the
following objectives: (i) to review the characteristics of
published economic evaluations of exercise-based CR
with exercise as the primary outcome of interest; (ii) to
evaluate the methodological quality of these CR
economic evaluations using the Consolidated Health
Economic Evaluation Reporting Standards (CHEERS)
checklist [8] and (iii) to make recommendations for fu-
ture economic evaluations of CR services. This descrip-
tive study will inform the quality of future research
addressing the cost-effectiveness of exercise rehabilita-
tion interventions.
Methods
Economic evaluation
Economic evaluations consist of partial or full analyses [3].
Partial evaluations assess either costs or consequences of
multiple interventions or both costs and consequences of
a single intervention. Full evaluations examine both costs
and consequences of multiple interventions [3]. This re-
view includes all forms of full economic evaluations, i.e.
cost-effectiveness, cost-benefit or cost-utility analyses.
Literature search strategy
The “PICO” statement was used to define the search cri-
teria for the review and identify the specifics of the pa-
tient population, intervention and the types of studies to
be evaluated. Electronic databases (Medline, Embase,
HTA, DARE, NHS EED and the Cochrane Library) were
searched for all (UK and worldwide) full economic eval-
uations of CR published in English between 2000 and
2014. The following text-word terms and MeSH head-
ings were used: cost, cost analysis, cost benefit, cost
effectiveness, cost minimisation, cost utility, economic
assessment, economic evaluation, health economics and
cardiac rehabilitation (Appendix 1). Hand searches of
bibliographies identified additional publications of which
any date was included. Hand searching references of
rejected publications also ensured that significant publi-
cations of relevance to the field were not missed. Grey
literature was not included, but this is unlikely to have
any significant effects on publication bias as most eco-
nomic evaluations are published or cited in scientific or
economic journals and will have been picked up through
the extensive online literature search.
Selection criteria
A study was considered if it met all the following inclu-
sion criteria:
(1)Adult patients with heart disease/failure who have
undergone myocardial infarction (MI) or
revascularisation (percutaneous transluminal
coronary angioplasty (PTCA) or coronary artery
bypass grafting (CABG)) and participated in a CR
program
(2)Intervention includes an exercise-based CR program
with follow-up
(3)A full-economic evaluation
Data extraction
Two reviewers (KE and RPV) independently selected eli-
gible publications. Disagreement between reviewers was
resolved through direct consultation. Data extraction
was carried out by a single reviewer (KE) and checked
by RPV. Data was extracted from eligible publications
on the following items from CHEERS [8]: target popula-
tion and subgroups, setting and location, study perspec-
tive, comparators, time horizon, choice of health
outcomes, measurement of effectiveness, measurement
and valuation of preference-based outcomes, estimating
resources and costs, choice of model, currency, price
date and conversion, characterising uncertainty and
characterising heterogeneity. Additional data was ex-
tracted on study design, sample demographics, exercise
dose, frequency and duration of follow-up, included
costs, chronic multimorbidity and findings.
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Quality assessment
The methodological quality of included evaluations was
assessed using CHEERS guidelines for each of the data
items extracted [8]. In addition to reporting whether in-
dividual studies meet the criteria for each of the data
items, their subsequent effects on the study results (such
as uncertainty) are examined. The guideline criteria as-
sess specific design elements of economic evaluations
for healthcare interventions. CHEERS is not known to
have previously been used to assess economic evalua-
tions of exercise-based CR interventions.
Results
Synthesis of evidence
The search strategy retrieved 716 citations, 23 qualified
for full-text review and eight were further excluded. Ex-
cluded were two literature reviews, one abstract, two
which only reported on study designs, one reporting on
an already included study, and two which were not full-
economic evaluations. Southard et al. [9] is not designed
as a full-economic evaluation and structured as a descrip-
tive assessment, but it was included as it examines both
health outcomes and costs between two CR interventions.
Figure 1 illustrates the review selection process.
Descriptive analysis
Descriptive characteristics of the 15 included economic
evaluations are provided in Appendix 2.
Dates, study design, perspective, time horizon and
location
The 15 included articles were published between 1991
and 2008, with twelve (80%) being based in the USA or
in Europe. Ten studies (67%) were based on randomised
clinical trials (RCTs) with time horizons ranging from 6
to 24 months. Twelve (80%) of the studies adopted a
cost-effectiveness or cost-utility approach, with the
remaining three taking the cost-benefit approach. Eight
(53%) of the included studies evaluated costs from the
perspective of the healthcare system, with three of those
additionally considering patient-borne costs (Table 1).
Program setting, comparators and target population
The comparisons assessed by the selected studies varied
greatly. They were undertaken based on various features
of the intervention such as where the CR program took
place, how exercise was incorporated into the program,
or even how the exercise component was delivered.
Taylor et al. [10] and Jolly et al. [11] compared hos-
pital- vs. home- exercise-based CR. Five studies com-
pared hospital-based CR interventions including
exercise: Briffa et al. [12] against conventional care
where it is unclear if exercise is a component; Levin et
al. [13] with standard care and no provision of regular
exercise; Dendale et al. [14] with no CR; Hall et al. [15]
with no formal CR but provision of a home-walking pro-
gram; and Ades et al. [16] devised a model based
Fig. 1 Flow of Review Selection Process
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primarily on hospital CR programs that were compared
to light/no exercise.
Four studies were at a rehabilitation facility: Papadakis
et al. [2] and Reid et al. [17] were based on the same trial
and evaluated service-delivery differences between a 3
and 12-month exercise-based CR program, whilst
Carlson et al. [18] compared a traditional exercise-based
program to one with tapered exercise sessions, and Yu
et al. [19] compared an exercise-based CR program to
conventional therapy without exercise.
Southard et al. [9] compared a home-based internet
program for monitoring patient exercise to usual care,
where it is unclear if exercise is a component.
In three studies, the setting of the exercise was un-
clear: the modelling study by Spronk et al. [20] com-
pared three exercise-based CR strategies; Huang et al.
[21] exercise-based CR to no-CR; and Oldridge et al. [4]
exercise-based CR against usual care, but did not specify
if exercise was a component of that care. Table 2 com-
pares the interventions of each study according to
program setting and exercise duration.
In twelve studies the target population included MI
patients, one included only PCI patients [14], another
only CABG patients [21], and one specified only low-
risk cardiac patients who experienced cardiovascular
surgery or an event (MI, PCI or CABG) [18].
Sample demographics, Subgroups and Comorbidities
Excluding the two modelling studies, the cohort study
employed the largest sample at 4324 patients [21]. In the
remaining trials, sample size ranged from 80 to 525
patients at initial recruitment; the majority were males
who in most cases accounted for over 72% of the overall
sample, with mean age ranging from 53 to 65 years.
Two studies conducted subgroup analyses, each look-
ing at different variables (e.g. age, sex, BMI, cardiac risk,
reason for referral) and extent of, if any, their effect on
costs [2, 21].
Nine studies made no reference to comorbidities. Three
excluded patients with major [10], life threatening or symp-
tomatic comorbidities [14], or where program participation
was prevented [11]. Two documented comorbidities, one
reporting only cardiovascular-related comorbidities
[12, 21]. One reported addressing co-morbidities but
provided no details [17]. No study reported analysing
data using comorbidities to stratify patients.
Dose of exercise
Excluding the two modelling studies [16, 20] and the co-
hort study [21], the exercise dose of interventions was
assessed using FITT (frequency, intensity, time and
type). Southard et al. [9] is classified as patient-
dependent for all variables due to the intervention being
home-based. Appendix 3 offers a detailed description of
exercise dose by intervention within each selected study.
Frequency
The remaining 11 evaluations reported patient exercise
frequency, with one referencing the original publication
[4, 22]. The frequency of provision for supervised exer-
cise sessions ranged from once-weekly [10] up to four-
times weekly [15], with the majority providing twice-
weekly sessions [2, 4, 13, 17, 19]. One combined data
from three hospital-based CR programs where the fre-
quency of exercise sessions was once-weekly, twice-
weekly and tapered [11].
Intensity
Eight studies reported patient exercise intensity, five dir-
ectly [11, 14, 17–19] and three through original trial
publications [2, 4, 13, 22, 23]. The threshold for exercise
intensity varied between these studies with the majority
aiming for between 60 and 85% maximum heart rate
capacity [4, 11, 18, 19]. Three did not report patient
exercise intensity [10, 12, 15].
Time
Seven evaluations directly reported the duration of
patient supervised exercise [11–14, 17–19], while two
referred to original trial publications [2, 4, 22]. In these
studies, exercise duration ranged from 30 to 120 min.
Two did not report exercise duration on their respective
CR programs [10, 15].
Table 1 Study design, location and study perspective of
included studies
Study Design Study Location Study Perspective
RCTs 10 (67%) UK Healthcare system and
patient
Societal
USA Healthcare system
Insurer
Canada Healthcare system
Healthcare system
Healthcare system
and patient
Australia Healthcare system
Healthcare system
and patient
Hong Kong Patient and provider
Non-RCTs 2 (13%) Belgium Healthcare system
Sweden Societal
Modelling Studies 2 (13%) USA Societal
Patient or Payer
Cohort Studies 1 (7%) USA Insurer
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Type
Nine evaluations directly reported, with varying detail, on
the type of exercise undertaken by CR program patients
[4, 11–15, 17–19], while two referred to original trial pub-
lications [2, 10, 24]. The majority involved aerobic exercise
training with some specifying the activities involved (e.g.
running, cycling, rowing, and circuits). Two stated only
that it was a low-level exercise program [4, 15], and one
that exercise was ‘consistent with guidelines for patients
with CAD’ (coronary artery disease) [17].
Health outcomes and measures of effectiveness
Included studies assessed a variety of health outcomes:
(i) HRQL, (ii) cardiovascular health, and (iii) survival.
Three were cost-benefit analyses and assessed the mon-
etary equivalent of cardiovascular events [9, 14] or total
cost over the study period [13]. Eight evaluated HRQL
outcomes: seven using the QALY as an effectiveness
measure and either the EQ-5D (using the UK value set
tariff ) [10, 11], time-trade off scores [3, 4, 19, 20], or
UBQ-H scores [12] as preference-based outcomes, while
one used a Quality-of-Life score derived from the Health
Measurement Questionnaire as an effectiveness measure
with no preference-based outcome [15]. Two evaluations
assessed cardiovascular health outcomes using factors
including peak oxygen consumption, cholesterol levels
or kilojoules of activity-related energy as measures of
effectiveness [17, 18]. Two looked at survival, with Years-
of-Life-Saved (YLS) as the effectiveness measure with no
preference-based outcome [16, 21] (Appendix 4).
Economic analysis
The following section reports on features of the health
economic analyses. Details are provided in Appendix 5.
Costs
All evaluations considered direct medical costs relating
to CR service-provision. Seven considered patient costs,
including direct expenses [12], travel [4, 10, 11, 15, 20],
time [4, 13, 20], equipment [4, 10] or childcare expenses
[4]. One also considered costs associated with employee
productivity loss from sick leave or early retirement [13].
Source of costs
Selected studies estimated costs from a combination of
sources, including hospital-derived data [2, 15, 20],
local/national publications [2, 12, 19], or health insur-
ance companies [13, 17, 21]. One used published data
from results of previous RCTs [16]. One did not report
the source of their cost data [18].
Currency, price date and conversion
The majority of studies reported costs in United States
dollars (USD$), with three having converted from
Table 2 Interventions compared by setting and duration of exercise
Duration of Exercise
No Exercise 1–2 weeks 6 weeks 8 weeks 9 weeks 3 months 6 months 12 months 24 months Un-specified
Jolly et al. (2007) [11] Home
Hosp
Home Hosp
Home Hosp
Home Hosp
Yu et al. (2004) [19] X Rehaba
Papadakis et al. (2007) [2] Rehaba Rehab
Briffa et al. (2005) [12] Hosp X
Hall et al. (2002) [15] Home Hosp
Taylor et al. (2007) [10] Home Hosp
(8–10)
Dendale et al. (2008) [14] X Hospb
Reid et al. (2005) [17] Rehab Rehab
Southard et al. (2003) [9] Homeb X
Carlson et al. (2000) [18] Rehab
Rehaba
Levin et al. (1991) [13] X Hospb
Oldridge et al. (1993) [4] Una X
(Setting of Exercise); Hosp = Hospital-based exercise intervention; Home = Home-based exercise intervention; Rehab = Exercise intervention based at
rehabilitation centre; No Ex = No exercise intervention; Un = Unclear (Significance Level); a statistically significant differences were identified for either cost or
health outcomes in favour of specified intervention arm, b statistically significant differences were identified in both cost and health outcomes in favour of
specified intervention arm
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Canadian dollars (CAN$) using a set exchange rate
[2, 4, 17]. Two reported costs in British Pounds (£)
[10, 11], two in Australian dollars (AUD$) [12, 15],
one in Euros (€) [14], and one in Swedish Kroner (SEK)
[13]. Two present costs in unspecified dollars, assumed to
be USD$ based on the authors’ affiliations [9].
Uncertainty
Nine evaluations characterised the uncertainty around
their results: three applied one-way sensitivity analysis
[11, 13, 16], Spronk et al. [20] used a combination of
one-way, two-way, multi-way and probabilistic sensitivity
analyses, and both Briffa et al. [12] and Taylor et al. [10]
combined sensitivity analysis and bootstrapping
methods. Huang et al. [21] used bootstrapping methods
alone, Papadakis et al. [2] combined this technique with
a cost-effectiveness acceptability curve (CEAC), and
Oldridge et al. [4] used scenario analysis to calculate the
plausible range of costs using the minimal, mean and
maximum estimates of direct medical costs per patient.
Heterogeneity
Only two evaluations performed subgroup analysis
allowing the presentation of results by patient sub-
groups: Huang et al. [21] reported Medicare expenditure
and survival by age, sex, race, number of cardiovascular
conditions, diagnosis of chronic obstructive pulmonary
disease (COPD), Medicare coverage, higher serum albu-
min, primary diagnosis of diabetes, AMI before CABG
and propensity for receiving CR, while Papadakis et al.
[2] provided mean incremental costs, QALYS gained
and incremental cost-effectiveness ratio (ICER) by
cardiac risk level, risk of disease progression, reason for
referral and sex.
Choice of model
The review included two modelling studies: Spronk et al.
[20] employed a Markov model to compare the cost-
effectiveness of three exercise-based CR strategies, and
Ades et al. [16] devised a statistical model to calculate
cost-effectiveness in Years-of-Life-Saved.
Findings
Hospital-based CR
Five evaluations compared hospital-based exercise in-
terventions: one to ‘standard’ care [13], one to ‘conven-
tional’ care [12], two with no-CR [14, 15], and one to
light/no exercise [16]. Against standard care, hospital-
based CR was highly cost-saving over 5 years, with
lower direct healthcare costs (3910SEK/€409), fewer
cardiovascular-related rehospitalisation’s (0.6 events/pa-
tient, non-significant) and less time receiving in-
hospital treatment (5.4 days, p < 0.05) [13]. Compared
to conventional care, survival advantages are reported
for hospital-CR patients where rehabilitation costs of
AUD$631(€471)/patient were offset by reduced follow-up
costs of AUD$236(€156)/patient and a non-significant gain
in quality-of-life up to a year [12]. Against no-CR, one
study found hospital-based CR cost €636 less/patient with
a reduced number of cardiovascular-related events (0.59
events/patient) [14]. Another estimated CR program cost
at AUD$300(€198) but, with non-significant differences
between costs and health outcomes compared to no-CR
patients, suggests savings may be made by targeting re-
habilitation to high-risk individuals [15]. Over 15-years,
hospital-based CR is reportedly highly cost-effective and
compares favourably to alternative treatments (e.g.
thrombolytic therapy, cholesterol-lowering drugs) with a
net incremental cost of USD$430 ($1280 vs $850)/€357
(€1063 vs €706), a discounted incremental life expectancy
of 0.202 years and an ICER of USD$4950(€4111)/YLS [16].
Home-based CR
One study used a home-based internet intervention to
monitor patient activity and as a platform for guidance
and interaction [9]. Over usual care, this had net cost-
savings of USD$965(€801)/patient and an 11.6% reduc-
tion in major cardiovascular events [9].
Hospital- versus home-based CR
Two evaluations examined cost-effectiveness between
hospital and home-based CR programs including exer-
cise [10, 11]. Neither found significant differences for
costs or health outcomes between patient groups. Taylor
et al. [10] found home-based CR had a lower mean cost/
patient due to reduced personnel costs (UK£30, 95% CI
-£45 to -£12/€32, 95% CI -€48 to -€13), but was associ-
ated with greater healthcare costs (UK£78, 95% CI, −
£1102 to £1191/€84, 95% CI -€1185 to €1281). Jolly et
al. [11] found home-based CR had higher direct rehabili-
tation costs to the health service (UK£41, 95% CI £26 to
£55/€44, 95% CI €28 to €59), even after including pa-
tient costs to the hospital-based arm. Each found a non-
significantly worse difference in health outcomes for
home-based patients with mean QALY differences of
−0.022 (95% CI -0.072 to −0.028) [11] or −0.06 (SD,
−0.15 to 0.02) [10] between interventions.
Centre-based CR
Four studies were based at a rehabilitation facility: two
compared 3 and 12-month exercise-based interventions
[2, 17], one a 6-month exercise program to one with ta-
pered sessions [18], and another exercise-based CR to
conventional care without exercise [19]. A 3-month CR
program cost USD$135(€112) less than a 12-month pro-
gram, with non-significant differences for exercise-
related variables, cardiac risk factors and HRQL [17].
With the same trial, another study showed the 3-month
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program had an incremental gain of 0.009 QALYs (95%
CI 0.004–0.013) and no significant cost differences to a
12-month program [2]. Sub-group analysis showed the
3-month program was dominant for patients with high-
risk of disease progression while the 12-month program
was preferential for PCI patients, suggesting triaging
patients may improve cost-effectiveness [2]. Another
study showed 6-month hospital-based CR with ta-
pered exercise sessions was USD$738(€612)/patient
cheaper than one with consistent thrice-weekly ses-
sions, but with no significant differences between
groups in outcome measures [18]. Against conven-
tional care without exercise, CR was USD$416(€345)/
patient cheaper with a 0.6 QALY gain after 2-years,
but non-significantly [19].
Three studies do not explicitly report exercise setting.
One compared three exercise-based CR strategies (CR
only, diagnostic work up for revascularisation before
CR or after CR failure), of which the latter was the
most favourable with a non-significant gain of 0.03
QALYs and an ICER of USD$44,251(€36,728)/QALY
over a patient lifetime compared to CR only [20].
Another study compared exercise-based CR to no-CR
finding over 3.5-years finding CR highly cost-effective, as-
sociated with a longer cumulative lifetime (76 days, 95%
CI 22–129 days) and ICER of USD$13,887(€11,526)/
YLS [21]. The remaining study concluded exercise-
based CR was an efficient use of healthcare resources
with a best incremental cost of USD$480(€398) and
mean QALY gain of 0.052 leading to an expected
ICER of USD$9200(€7638)/QALY (range USD$2300
to $182,800/€1910 to €151,769) over usual care [4].
Quality assessment
None of the 15 articles met all the CHEERS criteria for
included variables (Table 3). All 15 met the reporting
recommendations for study perspective and measure of
effectiveness. A mixture of studies fully or partially met
criteria for reporting target population, setting/location,
comparators, estimating resources and costs, and cur-
rency. Nine studies characterised the uncertainty of their
results, of which only seven fully met the criteria. Two
studies fully met the criteria for reporting choice of
health outcomes as others did not specify the rele-
vance of those chosen [2, 10]. Two studies performed
sub-group analysis, with only one reporting between
group variation for incremental costs, QALYs and
ICER values [2, 21]. None fully met the criteria for
time horizon, as none stated why that used was
appropriate. CHEERS assessment was based on the
content of individual articles only and not in conjunc-
tion with overlapping publications which may have
contained relevant information.
Discussion
This review assessed how economic evaluations of
exercise-based CR programs are conducted and evalu-
ated their methodological quality against the recently
published CHEERS guidelines for healthcare interven-
tions [8]. Exercise was the primary outcome of interest
in this review as it has proven health benefits [25] and is
a principal component of CR services; other aspects of
CR including psychological or educational interventions
were not evaluated.
An extensive literature search identified 15 economic
evaluations of exercise-based CR services. In consensus
with previous reviews we identified wide variability
amongst CR programs and service delivery [3, 5]. In this
review, such variability was particularly evident in study
perspective, time horizon, setting, comparators, included
costs, and in exercise dose (FITT) between interven-
tions. We critically appraised included evaluations
against recently expanded and updated economic guid-
ance, finding that none fully met the reporting criteria;
while included studies predated development of this
guidance, future studies may wish to adhere to these up-
to-date standards [8].
As most evaluations (10) were RCTs, their meticulous
patient selection process will question the wider general-
isability of their findings. Comparatively other study
types report higher proportions of males (60–89%) and
greater CR uptake (64–72%). [25]. Patients in these
RCTs were also younger than the average age distribu-
tion for CR participants (67 for men and 70 for women)
[25]. The use of short time horizons (6–24 months) also
seems incompatible with a chronic condition. Given the
likelihood that patients registering with a controlled trial
may be more inclined to adhere to exercise require-
ments, these elements suggest economic evaluations of
exercise-based CR programs using RCT’s risk providing
non-generalizable results.
Compared to RCT’s reporting non-conclusive or weak
results, evaluations utilising studies with longer time ho-
rizons (3.5 – 5 years) suggest a long-term exercise-based
CR program results in lower costs [13, 14], reduced hos-
pitalisations [13, 14], and longer cumulative lifetime
[21]. Longer follow-up times may allow for more bene-
fits of the intervention to be accrued and suggest that
interventions should be carried out with a long-
expanding time horizon.
Despite a reported 60–70% of cardiac patients acces-
sing CR services having comorbidities, these patients
were largely absent from included studies. This has
been recognised and it is estimated that 48% are
deemed inappropriate for rehabilitation by their refer-
rer [25]. In this review most studies failed to report co-
morbidities or simply excluded such patients [11, 12].
The likely presence of comorbidities in the population,
Edwards et al. Health Economics Review  (2017) 7:37 Page 7 of 23
Ta
b
le
3
Q
ua
lit
y
as
se
ss
m
en
t
of
in
cl
ud
ed
ec
on
om
ic
ev
al
ua
tio
ns
Ta
rg
et
Po
pu
la
tio
n/
Su
bg
ro
up
s
Se
tt
in
g/
Lo
ca
tio
n
St
ud
y
Pe
rs
pe
ct
iv
e
C
om
pa
ra
to
rs
Ti
m
e
H
or
iz
on
C
ho
ic
e
of
H
ea
lth
O
ut
co
m
es
M
ea
su
re
of
Ef
fe
ct
iv
en
es
s
M
ea
su
re
m
en
t
&
Va
lid
at
io
n
of
Pr
ef
er
en
ce
-b
as
ed
ou
tc
om
es
Es
tim
at
in
g
Re
so
ur
ce
s
an
d
C
os
ts
C
ur
re
nc
y,
pr
ic
e,
D
at
e
an
d
C
on
ve
rs
io
n
C
ho
ic
e
of
M
od
el
C
ha
ra
ct
er
is
in
g
U
nc
er
ta
in
ty
C
ha
ra
ct
er
is
in
g
H
et
er
og
en
ei
ty
Jo
lly
et
al
.
(2
00
7)
[1
1]
Y
Y
Y
Y
O
O
Y
Y
Y
Y
N
/A
O
N
Yu
et
al
.
(2
00
4)
[1
9]
Y
Y
Y
Y
O
O
Y
Y
O
O
N
/A
N
N
Pa
pa
da
ki
s
et
al
.
(2
00
7)
[2
]
Y
O
Y
Y
O
Y
Y
O
Y
Y
N
/A
Y
Y
Sp
ro
nk
et
al
.
(2
00
8)
[2
0]
Y
O
Y
Y
O
O
Y
Y
Y
Y
O
Y
N
Br
iff
a
et
al
.
(2
00
5)
[1
2]
Y
Y
Y
O
O
O
Y
Y
Y
Y
N
/A
O
N
H
al
le
t
al
.
(2
00
2)
[1
5]
Y
Y
Y
Y
O
O
Y
N
/A
O
Y
N
/A
O
N
Ta
yl
or
et
al
.
(2
00
7)
[1
0]
O
Y
Y
Y
O
Y
Y
O
Y
Y
N
/A
Y
N
D
en
da
le
et
al
.
(2
00
8)
[1
4]
Y
Y
Y
Y
O
O
Y
N
/A
Y
Y
N
/A
N
N
Re
id
et
al
.
(2
00
5)
[1
7]
Y
Y
Y
Y
O
O
Y
N
/A
O
Y
N
/A
N
N
So
ut
ha
rd
et
al
.
(2
00
3)
[9
]
Y
O
Y
O
O
O
Y
N
/A
O
O
N
/A
N
N
H
ua
ng
et
al
.
(2
00
8)
[2
1]
O
O
Y
Y
O
O
Y
N
/A
Y
Y
N
/A
Y
O
C
ar
ls
on
et
al
.
(2
00
0)
[1
8]
Y
Y
Y
Y
O
O
Y
N
/A
N
O
N
/A
N
N
Le
vi
n
et
al
.
(1
99
1)
[1
3]
Y
Y
Y
Y
O
O
Y
N
/A
O
Y
N
/A
Y
N
O
ld
rid
ge
et
al
.
(1
99
3)
[4
]
Y
O
Y
O
O
O
Y
O
O
Y
N
/A
Y
N
A
de
s
et
al
.
(1
99
7)
[1
6]
Y
Y
Y
Y
O
O
Y
N
/A
Y
Y
O
Y
N
Y
=
ye
s,
N
=
no
,O
=
pa
rt
ia
l,
N
/A
=
no
t
ap
pl
ic
ab
le
Edwards et al. Health Economics Review  (2017) 7:37 Page 8 of 23
particularly in older individuals, questions generalisabil-
ity of findings, and reflects a missed opportunity for
their management.
This review identified extensive heterogeneity between
studies in exercise dose (FITT) [25]. Session frequency
ranged from once to four times weekly, exercise inten-
sity was patient dependent or categorised in broad
groups (low, moderate or high intensity), and exercise
type often involved combinations of aerobic activity (e.g.
walking, running, cycling, rowing, arm cranking, dumb-
bell or weight training). This reflects a lack of knowledge
and absence of guidance on the most effective CR exer-
cise program. Standardising CR would allow more accur-
ate economic assessments, although risk eliminating the
potential for more cost-effective results to be obtained
from patient-dependent CR exercise regimes [18]. Alter-
natively, harmonising physical exercise dose into a com-
mon standard unit, such as the metabolic equivalent of
tasks (METs), would allow for an effective comparison
of the very diverse interventions found in the literature
[26, 27].
Generic quality-of-life measures (i.e. QALY) allow a
common measure across health conditions to facilitate
healthcare resource allocation, but their broad scope fails
to capture other health-related benefits outside the di-
mensions of the questionnaire (mobility, self-care, usual
activities, pain/discomfort and anxiety/depression in the
EQ-5D). The difficulty associated with measuring exer-
cise is a challenge for such interventions and its effects
has been captured elsewhere [28]. Exercise is known to
have far-reaching benefits proven effective at reducing
the disease burden of diabetes, osteoarthritis and cancer
[25], however generic HRQL instruments (e.g. EQ-5D
and the SF-36) are likely to be insensitive to detecting
change brought about by exercise-based CR [25]. Using
more specific outcome measures, such as the change in
physical activity level or evaluating the psychology of ex-
ercise behaviour (e.g. BREQ questionnaire), will provide
a more complete picture of the benefits produced by the
interventions and avoid producing inaccurate and mis-
leading cost-effectiveness results. Given many studies
found non-significant differences in costs between inter-
ventions, differences in health outcomes have the cap-
acity to be the main drivers of cost-effectiveness.
Appropriate criteria to detect and measure health
impact according to the specific study design must be
applied. [29–31].
All studies incorporated direct CR medical costs into
their evaluations, but lacked consistency in the types of
costs included and would likely result in two evaluations
of the same clinical study reporting different cost-
effectiveness results. Use of standardised cost categories
consistent with the study aims, perspective and nature
of exercise is recommended. For exercise-based CR, the
cost-savings attributable to reduced cardiovascular
events and potential reduction of general healthcare re-
source use should be reported. Given that several studies
found a non-significant difference in health outcomes
between interventions, costs are a potential driving force
behind cost-effectiveness.
Few studies reported statistically significant evidence
in both costs and effects for CR (Table 2). These were
predominantly cost-benefit analyses comparing exercise-
based CR to no exercise or where the use of exercise
was unclear [21]. Consequently, exercise-based CR
was considered cost-saving compared to CR without
exercise, and an effective secondary prevention
strategy in reducing subsequent cardiac events and
re-admissions, and increased survival [21]. Compara-
tively, other studies did not find significant evidence
identifying any interventions as conclusively cost-
effective, and this is likely due to inappropriate use of
time horizons, perspective, choice of health outcomes,
or cost categories.
Nevertheless, cost-effectiveness results can accurately
be non-conclusive. Only two evaluations performed sub-
group analysis, finding that interventions were more
cost-effective depending on gender and risk of disease
progression [2]. Given expected differences in cost and
health effects for patients of different gender, ages, dis-
ease severity, and comorbidities, subgroup analysis is
recommended to explore heterogeneity of results be-
tween relevant patient groups.
When analysing cost-effectiveness estimates for CR
evaluations, it is key to consider input uncertainty on
results, and observe whether statistical significance or
minimally important differences are achieved. Present-
ing only deterministic results can be misleading and
may show the intervention to be highly cost-effective,
yet closer scrutiny of the confidence intervals in some
cases reveals very limited certainty around the result
[4]. Findings should therefore be reported showing
deterministic results of the base case as well as sub-
group analyses and measures of uncertainty such as
confidence intervals and/or (probabilistic) sensitivity
analyses. These will provide a fair representation of
findings, statistical significance, achievement of MID,
and the potential effect of unknowns on the decision
to be made.
These findings provide the basis for the following rec-
ommendations for future economic evaluations of CR
programs:
(1)Include comorbid patients.
(2)Use of longer time-horizons (ideally lifetime) to cap-
ture the long-term health and cost-related outcomes
of exercise-based CR for chronic cardiovascular-
related conditions.
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(3)Develop an effective standardised exercise-based CR
program to enhance comparability of health out-
comes between studies.
(4)Develop standardised cost categories consistent with
the study perspective to enhance comparability of
economic findings between studies, potentially
including relevant non-health care costs such as
productivity loss.
(5)Adhere to up-to-date standards for economic evalu-
ations of healthcare interventions.
(6)Use subgroup analysis to capture the effects of
exercise-based CR on different patient groups.
(7)Use standardised reporting guidelines (e.g. CHEERS)
to enhance study comparability.
(8)Report confidence intervals, outcome measures and
MIDs to enhance the quality of methodological
reporting.
Crucially, following the above recommendations will
allow carers and providers to make better-informed
choices about the CR programs most suitable for their
specific patient groups or setting, as the particulars of
each will bring specific value weights to the various ele-
ments of the costs and outcomes associated to specific
modalities of CR programs.
Limitations of this review include incomplete retrieval
of all economic evaluations of exercise-based CR-
services, which may have arisen from the exclusion of
some electronic or grey literature sources. As most eco-
nomic evaluations are published or cited in economic
and scientific journals, it is likely these effects will be
minimal following an extensive literature search of sev-
eral online databases.
Conclusion
Evidence exists supporting the cost-effectiveness of
exercise-based CR for cardiovascular disease patients.
Variability between studies in study perspective, time
horizon, setting, comparators, included costs and inter-
ventions makes it difficult to compare and assess cost-
effectiveness between alternative strategies. Future stud-
ies may wish to consider the implications of an exercise-
based CR program for patients with comorbidities and
employ longer time-horizons. This will allow the long-
term effects of CR services to be better understood and
in a majority patient group that presents to this pathway.
Standardisation of CR service and delivery will enable
greater comparability between studies on a clinical and
cost level, with the program providing maximum
patient-provider benefit to be identified. Future eco-
nomic evaluations of exercise-based CR should adhere
to current guidelines for the reporting of healthcare in-
terventions. The methodology of cost-effectiveness
evaluations could be further improved to accommodate
different standards and processes between countries.
Appendix 1
Electronic search strategy: MEDLINE (OVID)
1 cost
2 costs
3 cost analysis
4 cost-analysis
5 cost analyses
6 cost-analyses
7 cost benefit
8 cost-benefit
9 cost benefit analysis
10 cost-benefit analysis
11 cost benefit analyses
12 cost-benefit analyses
13 cost effective
14 cost-effective
15 cost effectiveness
16 cost-effectiveness
17 cost effectiveness analysis
18 cost-effectiveness analysis
19 cost effectiveness analyses
20 cost-effectiveness analyses
21 cost minimisation
22 cost-minimisation
23 cost minimization
24 cost-minimization
25 cost minimisation analysis
26 cost-minimisation analysis
27 cost minimisation analyses
28 cost-minimisation analyses
29 cost minimization analysis
30 cost-minimization analysis
31 cost minimization analyses
32 cost-minimization analyses
33 cost utility
34 cost-utility
35 cost utility analysis
36 cost-utility analysis
37 cost utility analyses
38 cost-utility analyses
39 economic evaluation
40 economic assessment
41 health economics
42 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11
or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or
20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or
37 or 38 or 39 or 40 or 41
43 cardiac rehabilitation
44 42 and 43
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